Antenatal depression (AD) affects 7%–13% of pregnant women, with adverse implications for mother and child. Treatment often requires pharmacological intervention, typically with selective serotonin reuptake inhibitors (SSRIs). However, it remains unclear whether SSRIs introduce developmental consequences in children distinct from those associated with AD alone. This systematic review aims to elucidate the behavioral and neurological consequences of AD and prenatal SSRI exposure on child development.
Methods:
A systematic review of databases PubMed, PsycInfo, Web of Science, and Scopus was conducted using the PICO framework. Studies were eligible if they included at least two comparison groups: children with exposure to only AD (AD-only) and those exposed to both AD and in utero SSRIs (AD + SSRI). A total of 14 articles were included.
Results:
Studies report effects of both AD + SSRI and AD-only exposure on several measures. When compared to controls (CON), both AD + SSRI and AD-only displayed alterations in the corticolimbic system, abnormal language development, and increases in internalizing and externalizing problems. Specific to AD + SSRI were alterations in the corticothalamic system and impairment of psychomotor functioning. Specific to AD-only were steeper white matter volume increases across childhood and lower arousal scores as infants. No significant differences between AD + SSRI, AD-only, and CON were reported on attention and interference suppression. Notably, inconsistencies were found on several measurements, for example, IQ, cortical, and subcortical volume.
Conclusion:
We present an updated review of the potential implications of AD and SSRIs on child development. Ultimately, a preponderance of observational studies and numerous confounding factors make their effects difficult to disentangle, underscoring the need for further research.
AchenbachTM (1991) Integrative Guide for the 1991 CBCL/4-18, YSR, and TRF Profiles. Department of Psychiatry, University of Vermont.
2.
AprilianaTKeliatBAMustikasariM, et al. (2021) A contributing factor of maternal pregnancy depression in the occurrence of stunting on toddlers. Journal of Public Health Research11(2): 2738.
3.
de AraujoJSADelgadoIFPaumgarttenFJR (2020) Antenatal exposure to antidepressant drugs and the risk of neurodevelopmental and psychiatric disorders: A systematic review. Cadernos de Saude Publica36(2): e00026619.
4.
BairdHHarrisRASantosHP (2023) The effects of maternal perinatal depression on child IQ: A systematic review. Maternal and Child Health Journal27(9): 1489–1502.
5.
BraithwaiteECMurphySERamchandaniPG (2016) Effects of prenatal depressive symptoms on maternal and infant cortisol reactivity. Archives of Women’s Mental Health19(4): 581–590.
6.
BreauxRPHarveyEALugo-CandelasCI (2014) The role of parent psychopathology in the development of preschool children with behavior problems. Journal of Clinical Child and Adolescent Psychology43(5): 777–790.
7.
BriggsFUsreyWM (2008) Emerging views of corticothalamic function. Current Opinion in Neurobiology18(4): 403–407.
8.
BrivioPHombergJRRivaMA, et al. (2019) Alterations of glutamatergic markers in the prefrontal cortex of serotonin transporter knockout rats: A developmental timeline. Cellular and Molecular Neurobiology39(5): 715–720.
9.
BrummelteSGlanaghyEMBonninA, et al. (2017) Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation. Neuroscience342: 212–231.
10.
CalabreseFGuidottiGMiddelmanA, et al. (2013) Lack of serotonin transporter alters BDNF expression in the rat brain during early postnatal development. Molecular Neurobiology48(1): 244–256.
11.
CasperRCFleisherBELee-AncajasJC, et al. (2003) Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. The Journal of Pediatrics142(4): 402–408.
12.
CherewickMDahlREBertomenS, et al. (2023) Risk and protective factors for mental health and wellbeing among adolescent orphans. Health Psychology and Behavioral Medicine11(1): 2219299.
13.
ConnersCK (1997) Conners’ Rating Scales-Revised. Revised Technical Manual. Multi-Health Systems Inc.
DesaunayPEudeL-GDreyfusM, et al. (2023) Benefits and risks of antidepressant drugs during pregnancy: A systematic review of meta-analyses. Paediatric Drugs25(3): 247–265.
16.
El MarrounHWhiteTJHvan der KnaapNJF, et al. (2014) Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: Population-based study of young children. The British Journal of Psychiatry: The Journal of Mental Science205(2): 95–102.
17.
Faisal-CuryARochaACElise Machado Ribeiro SilottoA, et al. (2021) Prevalence and associated risk factors of antenatal depression among Brazilian pregnant women: A population-based study. Journal of Affective Disorders Reports5: 100166.
18.
FettesPSchulzeLDownarJ (2017) Cortico-Striatal-Thalamic loop circuits of the orbitofrontal cortex: Promising therapeutic targets in psychiatric illness. Frontiers in Systems Neuroscience11: 25.
19.
FigleyCRUddinMNWongK, et al. (2022) Potential pitfalls of using fractional anisotropy, axial diffusivity, and radial diffusivity as biomarkers of cerebral white matter microstructure. Frontiers in Neuroscience15: 799576.
GalballyMWatsonSJSpigsetO, et al. (2021) Antidepressant exposure in pregnancy and child sensorimotor and visuospatial development. Journal of Psychiatric Research143: 485–491.
22.
GaoS-YWuQ-JSunC, et al. (2018) Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: A systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Medicine16: 205.
23.
GentileS (2005) The safety of newer antidepressants in pregnancy and breastfeeding. Drug Safety28(2): 137–152.
24.
GentileSGalballyM (2011) Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: A systematic review. Journal of Affective Disorders128(1–2): 1–9.
25.
GilmanSESuchaEKingsburyM, et al. (2017) Depression and mortality in a longitudinal study: 1952–2011. CMAJ: Canadian Medical Association Journal189(42): E1304–E1310.
26.
GoedenNVelasquezJArnoldKA, et al. (2016) Maternal inflammation disrupts fetal neurodevelopment via increased placental output of serotonin to the fetal brain. The Journal of Neuroscience36(22): 6041–6049.
27.
GrahamAMRasmussenJMRudolphMD, et al. (2018) Maternal systemic interleukin-6 during pregnancy is associated with newborn amygdala phenotypes and subsequent behavior at 2 years of age. Biological Psychiatry83(2): 109–119.
28.
GreenbergPEFournierA-ASisitskyT, et al. (2021) The economic burden of adults with major depressive disorder in the United States (2010 and 2018). Pharmacoeconomics39(6): 653–665.
29.
GrieveSMWilliamsLMPaulRH, et al. (2007) Cognitive aging, executive function, and fractional anisotropy: A diffusion tensor MR imaging study. AJNR. American Journal of Neuroradiology28(2): 226–235.
30.
HamiltonM (1960) A Rating Scale for Depression. Journal of Neurology, Neurosurgery & Psychiatry23(1): 56–62.
31.
HermansenTKRøysambEAugustiE-M, et al. (2016) Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression. Psychopharmacology233(8): 1523–1535.
32.
HermansenTKYrttiahoSRøysambE, et al. (2017) Perceptual interference processing in preschool children, with and without prenatal exposure to selective serotonin reuptake inhibitors. Psychopharmacology234(3): 339–351.
33.
HernánMARobinsJM (2016) Using big data to emulate a target trial when a randomized trial is not available. American Journal of Epidemiology183(8): 758–764.
34.
HernánMAWangWLeafDE (2022) Target trial emulation: A framework for causal inference from observational data. JAMA328(24): 2446–2447.
35.
HombergJRSchubertDGasparP (2010) New perspectives on the neurodevelopmental effects of SSRIs. Trends in Pharmacological Sciences31(2): 60–65.
36.
HornungJ-P (2010) Chapter 1.3—The neuronatomy of the serotonergic system. In MüllerCPJacobsBL (eds.) Handbook of Behavioral Neuroscience. Elsevier, Vol. 21, pp. 51–64.
37.
HuangXKuangSApplegateTJ, et al. (2019) The development of the serotonergic and dopaminergic systems during chicken mid-late embryogenesis. Molecular and Cellular Endocrinology493: 110472.
38.
JahanNWentTRSultanW, et al. (2021) Untreated depression during pregnancy and its effect on pregnancy outcomes: A systematic review. Cureus13(8): e17251.
39.
JhaSCMeltzer-BrodySSteinerRJ, et al. (2016) Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study. Psychiatry Research. Neuroimaging253: 43–53.
40.
KalinNH (2020) The critical relationship between anxiety and depression. American Journal of Psychiatry177(5): 365–367.
KimMJFarberMJKnodtAR, et al. (2019) Corticolimbic circuit structure moderates an association between early life stress and later trait anxiety. NeuroImage: Clinical24: 102050.
43.
KocDEl MarrounHStrickerBH, et al. (2024) Intrauterine exposure to antidepressants or maternal depressive symptoms and offspring brain white matter trajectories from late childhood to adolescence. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging9(2): 217–226.
44.
KocDTiemeierHStrickerBH, et al. (2023) Prenatal antidepressant exposure and offspring brain morphologic trajectory. JAMA Psychiatry80(12): 1208–1217.
45.
KorkmanMKirkUKempS (2000) NEPSY: A Developmental Neuropsychological Assessment. Psychological Corporation.
46.
KovnerROlerJAKalinNH (2019) Cortico-Limbic interactions mediate adaptive and maladaptive responses relevant to psychopathology. The American Journal of Psychiatry176(12): 987–999.
47.
LatendresseGElmoreCDenerisA (2017) Selective serotonin reuptake inhibitors as first-line antidepressant therapy for perinatal depression. Journal of Midwifery & Women’s Health62(3): 317–328.
48.
LeismanGMelilloR (2013) The development of the frontal lobes in infancy and childhood: Asymmetry and the nature of temperament and affect. In: CavannaAE (ed.) Frontal lobe: Anatomy, functions and injuries. Nova Scientific.
49.
LesterBMTronickEZ (2004) History and description of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics113(3 Pt 2): 634–640.
50.
LinJLiuWGuanJ, et al. (2023) Latest updates on the serotonergic system in depression and anxiety. Frontiers in Synaptic Neuroscience15: 1124112.
51.
Lugo-CandelasCChaJHongS, et al. (2018) Associations between brain structure and connectivity in infants and exposure to selective serotonin reuptake inhibitors during pregnancy. JAMA Pediatrics172(6): 525–533.
52.
McArthurAKlugarovaJYanH, et al. (2020) Chapter 4: Systematic reviews of text and opinion. In: AromatarisEMunnZ (eds.) JBI Manual for Evidence Synthesis. JBI.
53.
Mohamed AliOVandermeerMRJSheikhHI, et al. (2018) Girls’ internalizing symptoms and white matter tracts in Cortico-Limbic circuitry. NeuroImage: Clinical21: 101650.
54.
MoreauALVossMHansenI, et al. (2023) Prenatal selective serotonin reuptake inhibitor exposure, depression, and brain morphology in middle childhood: Results from the ABCD study. Biological Psychiatry: Global Open Science3(2): 243–254.
55.
MunnZStoneJCAromatarisE, et al. (2023) Assessing the risk of bias of quantitative analytical studies: Introducing the vision for critical appraisal within JBI systematic reviews. JBI Evidence Synthesis21(3): 467.
56.
MyersSJohnsSE (2018) Postnatal depression is associated with detrimental life-long and multi-generational impacts on relationship quality. PeerJ6: e4305.
NulmanIKorenGRovetJ, et al. (2012) Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. The American Journal of Psychiatry169(11): 1165–1174.
59.
OberlanderTFWeinbergJPapsdorfM, et al. (2008) Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics3(2): 97–106.
60.
PageMJMcKenzieJEBossuytPM, et al. (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ372: n71.
61.
PetersSKDunlopKDownarJ (2016). Cortico-Striatal-Thalamic loop circuits of the salience network: A central pathway in psychiatric disease and treatment. Frontiers in Systems Neuroscience10: 104.
62.
Rotem-KohaviNWilliamsLJMullerAM, et al. (2019a) Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants. Depression and Anxiety36(8): 753–765.
63.
Rotem-KohaviNWilliamsLJVirji-BabulN, et al. (2019b) Alterations in resting-state networks following in utero selective serotonin reuptake inhibitor exposure in the neonatal brain. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging4(1): 39–49.
64.
RothbartMK (1981) Measurement of temperament in infancy. Child Development52(2): 569–578.
65.
RuedaMRFanJMcCandlissBD, et al. (2004) Development of attentional networks in childhood. Neuropsychologia42(8): 1029–1040.
66.
SalisburyALWisnerKLPearlsteinT, et al. (2011) Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depression and Anxiety28(11): 1008–1019.
67.
SantucciAKSingerLTWisniewskiSR, et al. (2014) Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes. The Journal of Clinical Psychiatry75(10): 1088–1095.
68.
SmagaIKrzyżanowskaWPomiernyB, et al. (2022) Neurotoxicity in depression. In: KostrzewaRM (ed.) Handbook of Neurotoxicity. Springer International Publishing, pp. 2085–2114.
69.
SoaresPSMde BarrosAJDdos SantosI, et al. (2024) Maternal mental health and offspring’s IQ: Evidence from two Brazilian birth cohorts. Journal of Affective Disorders351: 151–157.
70.
StegerMFKashdanTB (2009) Depression and everyday social activity, belonging, and well-being. Journal of Counseling Psychology56(2): 289–300.
71.
StroudLRPapandonatosGDParadeSH, et al. (2016) Prenatal major depressive disorder, placenta glucocorticoid and serotonergic signaling, and infant cortisol response. Psychosomatic Medicine78(9): 979–990.
72.
StrømlandE (2019) Preregistration and reproducibility. Journal of Economic Psychology75: 102143.
73.
SuriRLinASCohenLS, et al. (2014) Acute and long-term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: A review of the literature. The Journal of Clinical Psychiatry75(10): e1142–1152.
74.
VidebechPChristensenKSVinbergM (2023). Antidepressiv behandling af gravide—Information til sundhedsfaglige. Medicin.dk. Available at: https://pro.medicin.dk/Sygdomme/Sygdom/318339 (accessed 7 February 2024).
75.
WechslerD (2002) Wechsler Primary and Preschool Scale of Intelligence. The Psychological Corporation.
76.
WeikumWMOberlanderTFHenschTK, et al. (2012) Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proceedings of the National Academy of Sciences109(supplement_2): 17221–17227.
77.
WichmanCLSternTA (2015) Diagnosing and treating depression during pregnancy. The Primary Care Companion for CNS Disorders17(2): 10.4088/PCC.15f01776.
78.
WilderLSemendeferiK (2022) Infant brain development and plasticity from an evolutionary perspective. In: HartSLBjorklundDF (eds.) Evolutionary Perspectives on Infancy. Springer International Publishing, pp. 39–57.
79.
WomersleyKRipulloneKAgiusM (2017) What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence. Psychiatria Danubina29(Suppl 3): 629–644.
YinXSunNJiangN, et al. (2021) Prevalence and associated factors of antenatal depression: Systematic reviews and meta-analyses. Clinical Psychology Review83: 101932.
82.
YuJZhangZDengY, et al. (2023) Risk factors for the development of postpartum depression in individuals who screened positive for antenatal depression. BMC Psychiatry23(1): 557.
83.
ZafeiriouDIVerveriAVargiamiE (2009) The serotonergic system: Its role in pathogenesis and early developmental treatment of autism. Current Neuropharmacology7(2): 150–157.
84.
ZangrossiHDel BenCMGraeffFG, et al. (2020) Chapter 36—Serotonin in panic and anxiety disorders. In: MüllerCPCunninghamKA (eds.) Handbook of Behavioral Neuroscience. Elsevier, Vol. 31, pp. 611–633.
85.
ZhangT-NGaoS-YShenZ-Q, et al. (2017) Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: A meta-analysis of cohort studies. Scientific Reports7(1): 43085.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
